Noan (Diazepam)

Diazepam, the active ingredient in Noan, is a benzodiazepine presented as an oral tablet for oral use. It is employed to treat anxiety disorders, seizure disorders, muscle spasm, alcohol withdrawal and to provide sedation in adult patients.

GNH USA supplies Noan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diazepam is a benzodiazepine that acts on the central nervous system to manage several conditions.

- Anxiety disorders: reduces excessive anxiety and promotes calmness. - Seizure disorders: helps control various types of seizures. - Muscle spasm: relaxes skeletal muscle tone. - Alcohol withdrawal: alleviates tremor, agitation and risk of seizures. - Sedation: provides short‑term sedation for procedural or diagnostic purposes.

Diazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness - Fatigue - Muscle weakness - Impaired coordination - Dizziness - Headache

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Paradoxical reactions such as agitation or aggression - Dependence and withdrawal syndrome - Depression or suicidal thoughts - Severe skin reactions (e.g., Stevens‑Johnson syndrome)

Before prescribing Noan, clinicians should consider several safety factors.

- Pregnancy: category D; avoid unless benefits outweigh risks. - Elderly patients: increased sensitivity; start with the lowest effective dose. - History of substance abuse: heightened risk of dependence; monitor closely. - Concurrent CNS depressants: may amplify sedation and respiratory effects. - Operating machinery: avoid until the individual’s response to the drug is known. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Diazepam can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Opioids: additive respiratory depression. - Alcohol: enhanced sedative effect. - CYP3A4 inhibitors (e.g., ketoconazole): increased diazepam plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., carbamazepine): reduced effectiveness. - Antidepressants (SSRIs): may increase sedation. - Antihistamines: additive drowsiness.